title: In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.
abstract: An increase of urokinase-type plasminogen activator (uPA) and a decrease of tissue-type PA (tPA) have been associated with the transition from normal to adenomatous colorectal mucosa. Serial sections from 25 adenomas were used to identify PA-related caseinolytic activities by in situ zymography, blocking selectively uPA or tPA. The distribution of uPA, tPA, and type 1 PA inhibitor mRNAs was investigated by nonradioactive in situ hybridization, and the receptor for uPA was detected by immunostaining. Low- and high-grade epithelial cell dysplasia was mapped histologically. Results show that 23 of 25 adenomas expressed uPA-related lytic activity located predominantly in the periphery whereas tPA-related activity was mainly in central areas of adenomas. In 15 of 25 adenomas, uPA mRNA was expressed in stromal cells clustered in foci that coincided with areas of uPA lytic activity. The probability of finding uPA mRNA-reactive cells was significantly higher in areas with high-grade epithelial dysplasia. uPA receptor was mainly stromal and expressed at the periphery. Type 1 PA inhibitor mRNA cellular expression was diffuse in the stroma, in endothelial cells, and in a subpopulation of alpha-smooth muscle cell actin-reactive cells. These results show that a stromal up-regulation of the uPA/plasmin system is associated with foci of severe dysplasia in a subset of colorectal adenomas.
authors.affiliation: Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland.
authors.forename: I
authors.initials: I
authors.lastname: Sordat
authors.forename: P
authors.initials: P
authors.lastname: Chaubert
authors.forename: P
authors.initials: P
authors.lastname: Protiva
authors.forename: L
authors.initials: L
authors.lastname: Guillou
authors.forename: L
authors.initials: L
authors.lastname: Mazzucchelli
authors.forename: E
authors.initials: E
authors.lastname: Saraga
authors.forename: J
authors.initials: J
authors.lastname: Benhattar
authors.forename: C
authors.initials: C
authors.lastname: Trân-Thang
authors.forename: A L
authors.initials: AL
authors.lastname: Blum
authors.forename: G
authors.initials: G
authors.lastname: Dorta
authors.forename: B
authors.initials: B
authors.lastname: Sordat
mesh_terms: D000236:Adenoma / Q000201:enzymology* / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000473:pathology*; D004848:Epithelium / Q000201:enzymology / Q000473:pathology; D005341:Fibrinolysin / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D011956:Receptors, Cell Surface / Q000737:chemistry; D055293:Receptors, Urokinase Plasminogen Activator; D013194:Staining and Labeling; D017154:Stromal Cells / Q000201:enzymology / Q000473:pathology; D014568:Urokinase-Type Plasminogen Activator / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
chemical_list: C524898:PLAUR protein, human; D017395:Plasminogen Activator Inhibitor 1; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator